BCL2 and Alzheimer disease: The mRNA levels of Bcl2, Bax, and α-SMA in these three groups were measured; the results showed that the Bax mRNA levels were significantly increased in the Ang II group and further increased when treated with plasma from AD patients; the opposite trend of mRNA levels of Bcl2 and α-SMA was observed (Figure 4).